AKT Share Price Performance
د.م0
-1442.00 (-100.00%)
Price د.م0
Fair Valueد.م1,373.48
Share Pricen/a
Akdital S.A Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 45 Fair Values set on narratives written by author
AKT Community Narratives
AB
Fair Value
·Fair Value د.م1.37k 10.9% undervalued intrinsic discount
If Akdital maintains its growth momentum and avoids major execution pitfalls, it could become a regional healthcare leader
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
If Akdital maintains its growth momentum and avoids major execution pitfalls, it could become a regional healthcare leader
The Moroccan healthcare sector is expected to expand significantly, supported by government investment , population growth , and increased private sector participation. Universal health coverage (AMO) is also expanding, which should boost demand for private healthcare services, directly benefiting companies like Akdital.Read more
AB
د.م1.37k
10.9% undervalued intrinsic discount
Fair Value
Revenue
-95.07% p.a.
Profit Margin
10.65%
Future PE
54.5x
Price in 2030
د.م0
Trending Discussion
Recently Updated Narratives
AB
If Akdital maintains its growth momentum and avoids major execution pitfalls, it could become a regional healthcare leader
Fair Value: د.م1.37k 10.9% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Akdital S.A Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- 27.95
- 29.09%
- 10.42%
- 74.8%
About AKT
- Founded
- 2011
- Employees
- 6364
- CEO
- WebsiteView website
Akdital S.A operates in the healthcare sector in Morocco. The company offers its services in the areas of surgical, interventional medicine, critical and intensive care, maternity care, oncology, and diagnostic. It operates private hospitals, multidisciplinary, and specialized clinics and oncology centers. The company was founded in 2011 and is headquartered in Casablanca, Morocco.